当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析

迈威生物-U

(688062)

  

流通市值:116.70亿  总市值:228.41亿
流通股本:2.04亿   总股本:4.00亿

迈威生物-U(688062)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-5.52亿元,每股收益-1.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益100357.88万元,未分配利润-534658.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产446855.92万元,负债346498.04万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入101,165,449.1444,788,452.49199,781,622.22141,095,928.06
营业总成本671,700,790.36336,094,745.31,259,798,298.88844,467,620.3
其他经营收益
营业利润-552,442,829.55-291,020,952.63-1,043,479,690.64-692,034,701.16
利润总额-552,175,797.82-292,403,466.37-1,047,471,478.76-694,111,078.54
净利润-552,229,971.82-292,457,640.37-1,046,564,705.48-696,015,164.94
每股收益
其他综合收益-42,444.07-41,128.07278,847.66-1,015,688.86
综合收益总额-552,272,415.89-292,498,768.44-1,046,285,857.82-697,030,853.8
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,880,685,962.881,658,452,655.051,705,180,931.682,017,126,099.03
非流动资产:
非流动资产合计2,587,873,276.492,532,903,760.482,570,327,921.372,480,462,658.11
资产总计4,468,559,239.374,191,356,415.534,275,508,853.054,497,588,757.14
流动负债:
流动负债合计2,083,832,217.971,756,407,829.541,541,715,656.181,443,085,654.89
非流动负债:
非流动负债合计1,381,148,199.931,171,625,780.631,178,015,148.541,149,532,093
负债合计3,464,980,417.92,928,033,610.172,719,730,804.722,592,617,747.89
所有者权益(或股东权益):
归属于母公司股东权益合计818,070,486.771,277,151,626.391,568,877,364.271,917,349,658.51
股东权益合计1,003,578,821.471,263,322,805.361,555,778,048.331,904,971,009.25
负债和股东权益合计4,468,559,239.374,191,356,415.534,275,508,853.054,497,588,757.14
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计554,782,686.3159,382,060.81365,063,601.18299,141,739.35
经营活动现金流出小计588,707,146.94275,998,801.981,321,507,231.36967,362,530.41
经营活动产生的现金流量净额-33,924,460.63-216,616,741.17-956,443,630.18-668,220,791.06
投资活动产生的现金流量:
投资活动现金流入小计42,175,778.4532,155,778.45385,447,416.86322,059,417.02
投资活动现金流出小计142,401,820.0687,133,137.92677,001,577.43525,231,877.39
投资活动产生的现金流量净额-100,226,041.61-54,977,359.47-291,554,160.57-203,172,460.37
筹资活动产生的现金流量:
筹资活动现金流入小计1,167,140,000751,840,0003,608,373,290.692,242,633,290.69
筹资活动现金流出小计871,776,140.15570,707,471.022,776,675,458.471,415,498,893.27
筹资活动产生的现金流量净额295,363,859.85181,132,528.98831,697,832.22827,134,397.42
汇率变动对现金及现金等价物的影响-153,575.87-138,837.15232,889-933,514.53
现金及现金等价物净增加额161,059,781.74-90,600,408.81-416,067,069.53-45,192,368.54
期末现金及现金等价物余额1,388,625,946.971,136,965,756.421,227,566,165.231,598,440,866.22
补充资料:
现金及现金等价物的净增加额161,059,781.74--416,067,069.53-
最新报告期:2025-06-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东吴证券朱国广-0.68-1.38-0.572025-06-30
方正证券许睿,周超泽-1.48-0.700.262025-06-27
野村东方国际证券孔令岩,肖鸿德-1.81-0.610.032025-06-27
TOP↑